BioMedInvest in CHF106m final close
Swiss life sciences firm BioMed Partners has closed its second fund, BioMedInvest II, with CHF106m (€73m) in commitments.
Swiss life sciences firm BioMed Partners has closed its second fund, BioMedInvest II, with CHF106m (€73m) in commitments.